Home
>
Reference Standards>COX>
>
3-[4-(methylsulfonyl)phenyl]-4-phenyl-5-(trifluoromethyl)-isoxazole
For research use only. Not for therapeutic Use.
Many non-<wbr></wbr>steroidal anti-<wbr></wbr>inflammatory drugs (NSAIDs) are potent but non-<wbr></wbr>selective inhibitors of both COX-<wbr></wbr>1 and COX-<wbr></wbr>2 in humans. CAY10404 is one of the most selective inhibitors of COX-<wbr></wbr>2 which has been reported to date, with a selectivity index (SI; SI = IC<sub>50</sub> COX-<wbr></wbr>1/IC<sub>50</sub> COX-<wbr></wbr>2) of >500,000. (The COX-<wbr></wbr>1 IC<sub>50</sub> is >500 mM, and COX-<wbr></wbr>2 IC<sub>50</sub> is <1 nM.) As a reference point, the SI of celecoxib is about 400. Thus, CAY10404 has an SI which is several logs greater than the first generation of selective COX-<wbr></wbr>2 inhibitors, and is comparable to the SI of second generation selective COX-<wbr></wbr>2 inhibitors, such as valdecoxib and etoricoxib.
Catalog Number | R067349 |
CAS Number | 340267-36-9 |
Synonyms | 3-[4-(methylsulfonyl)phenyl]-4-phenyl-5-(trifluoromethyl)-isoxazole |
Molecular Formula | C17H12F3NO3S |
Purity | ≥95% |
Target | PI3K/Akt/mTOR |
Storage | -20°C |
IUPAC Name | 3-(4-methylsulfonylphenyl)-4-phenyl-5-(trifluoromethyl)-1,2-oxazole |
InChI | InChI=1S/C17H12F3NO3S/c1-25(22,23)13-9-7-12(8-10-13)15-14(11-5-3-2-4-6-11)16(24-21-15)17(18,19)20/h2-10H,1H3 |
InChIKey | KKBWWVXRKULXHF-UHFFFAOYSA-N |
SMILES | CS(=O)(=O)C1=CC=C(C=C1)C2=NOC(=C2C3=CC=CC=C3)C(F)(F)F |
Reference | 1.Barnett, J.,Chow, J.,Ives, D., et al. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys. Acta. 1209(1), 130-139 (1994). |